Fosravuconazole for Mycetoma (English x Japanese) скачать в хорошем качестве

Fosravuconazole for Mycetoma (English x Japanese)

Challenge Mycetoma (Eumycetoma), caused by a fungal infection, slowly and progressively destroys soft tissue, particularly on the feet. Mycetoma has no effective treatment and is currently managed with sub-optimal, expensive drugs carrying strong side effects and often requiring surgery, including amputation of affected limbs. In rare cases, it affects the lungs or brain and can be fatal. In all cases, patients are unable to work and face severe social stigma. Innovation Fosravuconazole, originally developed by Eisai to treat other fungal infections, has a proven safety profile and shows strong in vitro antifungal activity against mycetoma. This candidate drug can be administered once weekly and would drastically improve patient compliance and reduce costs for individuals and health systems alike. This drug, if successful, could transform their quality of life. Development Partners Eisai Co., Ltd., Drugs for Neglected Diseases initiative, and Mycetoma Research Centre at the University of Khartoum Know more https://www.ghitfund.org/investment/p... 🔗GHIT Fund ☞ https://www.ghitfund.org/jp 🗨️Twitter ☞   / ghitfund   🗨️LinkedIn ☞   / ghitfund   #公益社団法人グローバルヘルス技術振興基金 #グローバルヘルス #GlobalHealth #GHITFund #GHIT #マラリア #Malaria #結核 #Tuberculosis #顧みられない熱帯病 #NTDs #NeglectedTropicalDiseases